Glycobiology Advance Access originally published online on September 21, 2005
Glycobiology 2006 16(2):132-145; doi:10.1093/glycob/cwj042
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA
3 Unitat de Bioquímica i Biologia Molecular, Departament de Biologia, Universitat de Girona, Campus de Montilivi s/n. 17071, Girona, Catalonia, Spain; 4 Laboratori ICS Girona, Hospital Universitari Dr Josep Trueta, Avinguda de França s/n. 17007, Girona, Catalonia, Spain; 5 Glycobiology Institute, Department of Biochemistry, Oxford University, Oxford OX1 3QU, UK; and 6 Roche Diagnostics GmbH, Nonnenwaldstrasse 2, 82372 Penzberg, Germany
1 To whom correspondence should be addressed; e-mail: pauline.rudd{at}bioch.ox.ac.uk
2 To whom correspondence should be addressed; e-mail: rosa.peracaula{at}udg.es
Received on July 27, 2005; revised on September 14, 2005; accepted on September 16, 2005
Prostate-specific antigen (PSA), the tumor marker currently used for prostate cancer (PCa), is not specific enough to distinguish between PCa and benign prostate hyperplasia (BPH). Glycan processing is normally perturbed in tumors, therefore we investigated whether changes in glycosylation of PSA could be useful diagnostic indicators. Previously we determined that the glycosylation of PSA secreted by the tumor prostate cell line LNCaP differs significantly from that of PSA from seminal plasma (normal control). We therefore undertook a detailed glycan analysis of PSA derived from sera from PCa patients and, importantly, established that the glycosylation of the PCa serum PSA was significantly different from the PSA from the LNCaP cell line. In comparison with seminal plasma PSA, the fucose content of PSA from the PCa patient serum was significantly lower and there was a decrease in a2,3-linked sialic acid. Differences in the glycosylation of PSA derived from PCa patients’ sera, seminal plasma, and LNCaP cells were further established by lectin detection, glycosylation immunosorbent assay, and two-dimensional electrophoresis. We also investigated whether the impact of glycosylation changes initiated by the tumor was reflected in the serum glycome. By comparing the glycans released from the total glycoproteins in PCa patient serum with those of normal serum we found an increase in the proportion of sialyl-Lewis x structures. Further analysis of the glycosylation of PSA from PCa and BPH sera will be required in order to determine the utility of these glycan differences to discriminate specifically between benign and malignant prostate states.
Key words: lectins / N-glycosylation / prostate cancer / prostate-specific antigen / two-dimensional electrophoresis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Jia, Z. Lu, Y. Fu, H.-P. Wang, L.-H. Wang, H. Chi, Z.-F. Yuan, Z.-B. Zheng, L.-N. Song, H.-H. Han, et al. A Strategy for Precise and Large Scale Identification of Core Fucosylated Glycoproteins Mol. Cell. Proteomics, May 1, 2009; 8(5): 913 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kuno, Y. Kato, A. Matsuda, M. K. Kaneko, H. Ito, K. Amano, Y. Chiba, H. Narimatsu, and J. Hirabayashi Focused Differential Glycan Analysis with the Platform Antibody-assisted Lectin Profiling for Glycan-related Biomarker Verification Mol. Cell. Proteomics, January 1, 2009; 8(1): 99 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. M Abd Hamid, L. Royle, R. Saldova, C. M Radcliffe, D. J Harvey, S. J Storr, M. Pardo, R. Antrobus, C. J Chapman, N. Zitzmann, et al. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression Glycobiology, December 1, 2008; 18(12): 1105 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Alavi and J. S. Axford Sweet and sour: the impact of sugars on disease Rheumatology, June 1, 2008; 47(6): 760 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tajiri, C. Ohyama, and Y. Wada Oligosaccharide Profiles of the Prostate Specific Antigen in Free and Complexed Forms from the Prostate Cancer Patient Serum and in Seminal Plasma: a Glycopeptide Approach Glycobiology, January 1, 2008; 18(1): 2 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Saldova, L. Royle, C. M Radcliffe, U. M Abd Hamid, R. Evans, J. N Arnold, R. E Banks, R. Hutson, D. J Harvey, R. Antrobus, et al. Ovarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgG Glycobiology, December 1, 2007; 17(12): 1344 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Drake, E. E. Schwegler, G. Malik, J. Diaz, T. Block, A. Mehta, and O. J. Semmes Lectin Capture Strategies Combined with Mass Spectrometry for the Discovery of Serum Glycoprotein Biomarkers Mol. Cell. Proteomics, October 1, 2006; 5(10): 1957 - 1967. [Abstract] [Full Text] [PDF]
|
|